Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Drug therapy for multiple sclerosis.
Tumor necrosis factor beta NcoI polymorphism is associated with inflammatory and metabolic markers in multiple sclerosis patients.
Walking capacity and ability are more impaired in progressive compared to relapsing type of multiple sclerosis.
Using the random forest method to detect a response shift in the quality of life of multiple sclerosis patients: a cohort study.
Multiple sclerosis: Infertility treatment increases multiple sclerosis activity.
Cerebrospinal Fluid High-Mobility Group Box Protein 1 in Neuromyelitis Optica and Multiple Sclerosis.
Nature plus nurture: the triggering of multiple sclerosis.
A salty taste to autoimmunity.
Autophagy in immunity: Implications in etiology of autoimmune/autoinflammatory diseases.
2014 multiple sclerosis therapeutic update.
How much sunlight is enough?
Defining the new end point for multiple sclerosis treatment.
The organization of the sphingosine 1-phosphate signaling system.
Chronic deep brain stimulation for the treatment of tremor in multiple sclerosis: review and case reports.
A Systematic Review of Randomized, Double-Blind, Placebo-Controlled Trials Examining the Clinical Efficacy of Vitamin D in Multiple Sclerosis.
Ciliary Neurotrophic Factor Role in Myelin Oligodendrocyte Glycoprotein Expression in Cuprizone-Induced Multiple Sclerosis Mice.
Design of a regulated lentiviral vector for hematopoietic stem cell gene therapy of globoid cell leukodystrophy.
Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis.
Sodium channel Nav1.8: Emerging links to human disease.
Patient-related factors may affect the outcome of neuropsychological rehabilitation in multiple sclerosis.
Demyelination and other neurological adverse events after anti-TNF therapy.
Cognition and eye movements: assessment of cerebral dysfunction.
Changes in tissue directionality reflect differences in myelin content after demyelination in mice spinal cords.
Bee Venom Acupuncture Alleviates Experimental Autoimmune Encephalomyelitis by Upregulating Regulatory T Cells and Suppressing Th1 and Th17 Responses.
Weekly multimodal MRI follow-up of two multiple sclerosis active lesions presenting a transient decrease in ADC.
Pages
« first
‹ previous
…
314
315
316
317
318
319
320
321
322
…
next ›
last »